Development Pipeline
as of February, 2026
| Therapeutic Area | Development Code (Generic name) |
Development Stage | Indication | Note |
|---|---|---|---|---|
| Gastrointestinal diseases |
AJG555 | Submission |
Chronic constipation in children under 2 years of age |
Oral |
| AJM347 | Phase Ⅰ | Inflammatory bowel disease | Oral | |
| EA1080 | Phase Ⅰ | Inflammatory bowel disease | Oral | |
| EA3571 | Phase Ⅰ | Nonalcoholic steatohepatitis | Oral | |
| Mental disorder | EA8001 | Phase Ⅲ |
Treatment-resistant schizophrenia with an inadequate response to at least two antipsychotics |
Oral |
※スワイプできます
※表は左右にスクロールできます